Fondren Management’s Opiant Pharmaceuticals, Inc. Common Stock OPNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | $1.03M | Sell |
137,000
-49,900
| -27% | -$373K | 6.05% | 6 |
|
|
2020
Q2 | $1.69M | Sell |
186,900
-127,400
| -41% | -$1.15M | 6.53% | 6 |
|
|
2020
Q1 | $3.01M | Buy |
314,300
+49,400
| +19% | +$473K | 7.65% | 2 |
|
|
2019
Q4 | $3.82M | Sell |
264,900
-20,248
| -7% | -$292K | 3.91% | 5 |
|
|
2019
Q3 | $4.29M | Buy |
285,148
+67,836
| +31% | +$1.02M | 3.57% | 5 |
|
|
2019
Q2 | $2.88M | Buy |
217,312
+138,312
| +175% | +$1.83M | 2.74% | 11 |
|
|
2019
Q1 | $1.04M | Buy |
+79,000
| New | +$1.04M | 0.82% | 31 |
|